- Aug 11, 2023
Refined Stratification and Frontline Targeted Therapies Explored in Pediatric T-ALL
The treatment of pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) has benefited from numerous advancements in...
- Aug 26, 2022
New chemical technology leads to better targeted therapeutics against high-risk leukemia in the lab
Scientists from St. Jude Children’s Research Hospital have created an LCK targeted PROTAC, demonstrating its enhanced ability to kill...
- Jul 4, 2017
First large-scale genomic analysis of key acute leukemia will likely yield new therapies
A consortium including St. Jude Children's Research Hospital and the Children's Oncology Group has performed an unprecedented genomic...